Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
IJRM-International Journal of Reproductive Biomedicine. 2017; 15 (7): 429-434
en Inglés | IMEMR | ID: emr-189255

RESUMEN

Background: Gonadotropin-releasing hormone agonists [GnRH-a] was increasingly used for triggering oocyte maturationfor the prevention of ovarian hyperstimulation syndrome. Studies suggest that GnRH-a might be used as a better trigger agent since it causes both Luteinizing hormone and follicle stimulating hormone release from a physiologic natural cycle


Objective: The aim of this study was to evaluate the effect of dual-triggering in assisted reproductive technology outcomes


Materials and Methods: 192 normal responder women aged

Results: The mean of retrieved oocytes and obtained embryos were statistically higher in the dual-trigger group [group I], but the implantation and pregnancy rates were similar in two groups


Conclusion: The results of our study did not confirm the favorable effect of dual-triggered oocyte maturation with a GnRH-a and a standard dosage of hCG as an effective strategy to optimize pregnancy outcome for normal responders in GnRH-antagonist cycles. We think that this new concept requires more studies before becoming a universal controlled ovarian hyperstimulation protocol in vitro fertilization practice


Asunto(s)
Humanos , Femenino , Adulto , Hormona Liberadora de Gonadotropina/agonistas , Gonadotropina Coriónica/farmacología , Técnicas Reproductivas Asistidas , Método Simple Ciego
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA